GSK Announces Board ChangesBy
GlaxoSmithKline (GSK) plc reports that Sir Christopher Gent will step down as Chairman of GSK at the company's annual general meeting on May 7,2015. He will be succeeded by Sir Philip Hampton with effect from the end of the AGM. Sir Philip joined GSK's Board as an independent Non-Executive Director on January 1, 2015, and will become deputy chairman on April 1, 2015. Sir Philip chairs the company's Nominations Committee. He will remain chairman of RBS until August 31, 2015.
In addition, Tom de Swaan, independent non executive director, is not seeking re-election to the board at the AGM. He has been a board member for nine years and is currently chairman of the Remuneration Committee and a member of the Audit & Risk Committee (of which he was previously chairman), and the Nominations Committee. A successor for Mr. de Swaan as chairman of the Remuneration Committee will be announced in due course said GSK. Also, Jing Ulrich has decided not to stand for re-election to the Board at the AGM.